It suppresses the expression of VEGF and basic fibroblast growth factor (bFGF), thereby inhibiting angiogenesis and reducing the blood supply to the tumor, which limits RCC growth and metastasis [47]. Here, FGF2 is linked to renal cell carcinoma.